Loading...

Medpace Holdings, Inc. Peer Comparison

Metric Value Ranking
Market Cap $10.5 Billion 7/12 IDXX
$37.4B
IQV
$35.9B
MTD
$27.5B
WAT
$22.7B
LH
$20.2B
ICLR
$15.4B
MEDP
$10.5B
QGEN
$8.7B
CRL
$7.9B
SYNH
$4.5B
TWST
$2.8B
NEOG
$2.2B
Gross Margin -38% 12/12 MTD
64%
WAT
63%
QGEN
61%
IDXX
61%
NEOG
49%
TWST
45%
IQV
35%
CRL
35%
LH
27%
ICLR
25%
SYNH
22%
MEDP
-38%
Profit Margin 18% 5/12 IDXX
24%
WAT
22%
MTD
22%
QGEN
20%
MEDP
18%
IQV
11%
ICLR
10%
CRL
7%
LH
4%
SYNH
0%
TWST
-41%
NEOG
-100%
EBITDA margin 118% 1/12 MEDP
118%
QGEN
35%
IQV
26%
MTD
23%
IDXX
21%
ICLR
19%
CRL
12%
SYNH
8%
LH
7%
WAT
6%
TWST
-43%
NEOG
-198%
Quarterly Revenue $533.3 Million 9/12 IQV
$4.0B
LH
$3.3B
ICLR
$2.0B
SYNH
$1.4B
CRL
$1.0B
IDXX
$975.5M
MTD
$954.5M
WAT
$740.3M
MEDP
$533.3M
QGEN
$501.9M
NEOG
$231.3M
TWST
$84.7M
Quarterly Earnings $96.5 Million 8/12 IQV
$437.0M
IDXX
$232.8M
MTD
$211.5M
ICLR
$197.1M
WAT
$161.5M
LH
$143.4M
QGEN
$98.1M
MEDP
$96.5M
CRL
$69.7M
SYNH
$793,000
TWST
-$34.7M
NEOG
-$456.3M
Quarterly Free Cash Flow $167.4 Million 6/12 ICLR
$370.1M
MTD
$233.2M
CRL
$213.1M
IDXX
$192.0M
WAT
$179.0M
MEDP
$167.4M
QGEN
$138.0M
NEOG
$78.7M
SYNH
-$51.6M
LH
-$0
IQV
-$0
TWST
-$0
Trailing 4 Quarters Revenue $2.1 Billion 9/12 IQV
$15.4B
LH
$13.0B
ICLR
$6.2B
SYNH
$5.4B
CRL
$4.1B
IDXX
$3.8B
MTD
$3.8B
WAT
$2.9B
MEDP
$2.1B
QGEN
$2.0B
NEOG
$913.8M
TWST
$313.0M
Trailing 4 Quarters Earnings $365.7 Million 8/12 IQV
$4.0B
LH
$3.3B
ICLR
$2.0B
SYNH
$1.4B
CRL
$1.0B
IDXX
$975.5M
MTD
$954.5M
WAT
$740.3M
MEDP
$533.3M
QGEN
$501.9M
NEOG
$231.3M
TWST
$84.7M
Quarterly Earnings Growth 37% 2/12 LH
186%
MEDP
37%
QGEN
26%
TWST
25%
WAT
20%
ICLR
20%
IDXX
10%
MTD
5%
IQV
-7%
CRL
-20%
SYNH
-99%
NEOG
-12985%
Annual Earnings Growth 44% 2/12 LH
87%
MEDP
44%
CRL
9%
WAT
6%
ICLR
4%
TWST
4%
IQV
0%
IDXX
-2%
MTD
-6%
SYNH
-67%
QGEN
-71%
NEOG
-46707%
Quarterly Revenue Growth 8% 3/12 TWST
27%
LH
10%
MEDP
8%
IDXX
7%
QGEN
5%
WAT
4%
IQV
2%
MTD
1%
NEOG
1%
SYNH
0%
ICLR
-1%
CRL
-2%
Annual Revenue Growth 10% 2/12 TWST
21%
MEDP
10%
LH
7%
IDXX
3%
IQV
2%
SYNH
1%
QGEN
0%
NEOG
0%
WAT
-1%
CRL
-3%
MTD
-3%
ICLR
-23%
Cash On Hand $656.9 Million 5/12 IQV
$1.7B
LH
$1.5B
QGEN
$973.0M
ICLR
$695.5M
MEDP
$656.9M
WAT
$331.5M
IDXX
$308.6M
TWST
$226.3M
CRL
$210.2M
NEOG
$140.2M
SYNH
$82.2M
MTD
$71.6M
Short Term Debt $670.9 Million 12/12 LH
$1.2B
IQV
$1.1B
QGEN
$555.3M
IDXX
$349.1M
MTD
$185.8M
SYNH
$68.3M
ICLR
$29.8M
WAT
$25.3M
TWST
$14.8M
CRL
$3.2M
NEOG
$2.6M
MEDP
-$670.9M
Long Term Debt $128.3 Million 10/12 ICLR
$3.4B
SYNH
$2.8B
CRL
$2.8B
MTD
$1.9B
QGEN
$1.4B
NEOG
$889.9M
LH
$750.6M
IDXX
$524.8M
IQV
$173.0M
MEDP
$128.3M
TWST
$70.2M
WAT
$0
PE 28.60 7/12 QGEN
94.02
SYNH
62.59
IDXX
43.23
WAT
36.42
MTD
34.51
ICLR
28.98
MEDP
28.60
LH
27.04
IQV
26.15
CRL
19.02
NEOG
-1.00
TWST
-1.00
PS 5.05 5/12 IDXX
9.74
TWST
8.81
WAT
7.81
MTD
7.30
MEDP
5.05
QGEN
4.44
ICLR
2.47
NEOG
2.36
IQV
2.33
CRL
1.94
LH
1.55
SYNH
0.82
PB 11.86 3/12 IDXX
23.15
WAT
14.15
MEDP
11.86
IQV
5.92
TWST
5.83
LH
2.50
QGEN
2.48
CRL
2.06
ICLR
1.58
SYNH
1.28
NEOG
0.81
MTD
0.00
PC 15.92 8/12 MTD
383.59
IDXX
121.34
WAT
68.41
SYNH
54.25
CRL
37.47
ICLR
22.14
IQV
21.10
MEDP
15.92
NEOG
15.39
LH
13.28
TWST
12.18
QGEN
8.98
Liabilities to Equity 1.36 3/12 IQV
3.43
WAT
1.81
MEDP
1.36
SYNH
1.31
LH
1.28
CRL
1.10
IDXX
1.07
MTD
1.05
QGEN
0.78
ICLR
0.76
NEOG
0.52
TWST
0.30
ROA 0.18 3/12 IDXX
26%
MTD
24%
MEDP
18%
WAT
14%
IQV
5%
CRL
5%
LH
4%
ICLR
3%
SYNH
1%
QGEN
1%
NEOG
-12%
TWST
-34%
ROE 0.41 2/12 IDXX
54%
MEDP
41%
WAT
39%
MTD
24%
IQV
23%
CRL
11%
LH
9%
ICLR
5%
QGEN
3%
SYNH
2%
NEOG
-18%
TWST
-44%
Current Ratio 1.73 9/12 TWST
4.34
NEOG
2.93
ICLR
2.31
QGEN
2.29
IDXX
1.93
CRL
1.92
LH
1.78
SYNH
1.76
MEDP
1.73
WAT
1.55
IQV
1.29
MTD
0.96
Quick Ratio 0.55 2/12 QGEN
94.02
SYNH
62.59
IDXX
43.23
WAT
36.42
MTD
34.51
ICLR
28.98
MEDP
28.60
LH
27.04
IQV
26.15
CRL
19.02
NEOG
-1.00
TWST
-1.00
Long Term Debt to Equity 0.15 8/12 SYNH}
0.81
CRL}
0.73
MTD}
0.57
QGEN}
0.39
ICLR}
0.35
NEOG}
0.33
IDXX}
0.32
MEDP}
0.15
TWST}
0.15
LH}
0.09
IQV}
0.03
WAT}
0.00
Debt to Equity 0.15 11/12 SYNH
0.83
CRL
0.73
MTD
0.63
QGEN
0.54
IDXX
0.54
ICLR
0.35
NEOG
0.33
LH
0.24
IQV
0.22
TWST
0.18
MEDP
0.15
WAT
0.02
Burn Rate -2.54 10/12 QGEN
10.21
LH
8.24
TWST
5.50
CRL
5.06
SYNH
0.64
NEOG
0.28
MTD
-0.80
WAT
-2.14
IDXX
-2.48
MEDP
-2.54
IQV
-11.83
ICLR
-12.98
Cash to Cap 0.06 4/12 QGEN
0.11
LH
0.08
TWST
0.08
MEDP
0.06
NEOG
0.06
IQV
0.05
ICLR
0.05
CRL
0.03
SYNH
0.02
IDXX
0.01
WAT
0.01
MTD
0.00
CCR 1.74 3/12 CRL
3.06
ICLR
1.88
MEDP
1.74
QGEN
1.41
WAT
1.11
MTD
1.10
IDXX
0.82
NEOG
-0.17
SYNH
-65.12
LH
IQV
TWST
EV to EBITDA 15.84 10/12 WAT}
534.61
IDXX}
183.12
MTD}
136.22
LH}
95.12
CRL}
88.79
SYNH}
64.31
QGEN}
54.43
ICLR}
46.34
IQV}
34.72
MEDP}
15.84
NEOG}
-6.36
TWST}
-72.54
EV to Revenue 4.79 6/12 IDXX
9.89
TWST
8.35
MTD
7.83
WAT
7.70
QGEN
4.93
MEDP
4.79
NEOG
3.19
ICLR
2.91
CRL
2.57
IQV
2.31
LH
1.58
SYNH
1.34